Novo Nordisk’s (NOVOB) Sell Rating Reiterated at J P Morgan Chase & Co

J P Morgan Chase & Co reiterated their sell rating on shares of Novo Nordisk (SWX:NOVOB) in a report released on Monday morning.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by sleekmoney and is owned by of sleekmoney. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://sleekmoney.com/novo-nordisks-novob-sell-rating-reiterated-at-j-p-morgan-chase-co/1932839.html.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/novo-nordisks-novob-sell-rating-reiterated-at-j-p-morgan-chase-co/1932839.html

Receive News & Ratings for Novo Nordisk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *